{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:18:17Z","timestamp":1791865097134,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jac\/dkx136","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T11:11:59Z","timestamp":1492513919000},"page":"2278-2289","source":"Crossref","is-referenced-by-count":121,"title":["Activity of ceftolozane\/tazobactam against surveillance and \u2018problem\u2019 Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles"],"prefix":"10.1093","volume":"72","author":[{"given":"David M.","family":"Livermore","sequence":"first","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazad","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Meunier","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hill","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Adkin","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiysha","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pike","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Staves","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Woodford","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the BSAC Resistance Surveillance Standing Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"key\n\t\t\t\t20180313122641_dkx136-B1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1060028015593293","article-title":"Ceftolozane\/tazobactam: a new cephalosporin and \u03b2-lactamase inhibitor combination","volume":"49","author":"Sucher","year":"2015","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijantimicag.2009.03.021","article-title":"Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates","volume":"34","author":"Livermore","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B4","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/jac\/dkn349","article-title":"Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes","volume":"62","author":"Reynolds","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B5","first-page":"1","article-title":"A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy","volume":"27","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/48.suppl_1.87","article-title":"Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes","volume":"48","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/25.2.199","article-title":"Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I \u03b2-lactamases","volume":"25","author":"Akova","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B8","first-page":"38","article-title":"Chromosomal \u03b2-lactam resistance in enterobacteria","volume":"49","author":"Normark","year":"1986","journal-title":"Scand J Infect Dis Suppl"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.43.4.769","article-title":"Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates","volume":"43","author":"Poirel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/dkp029","article-title":"Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK","volume":"63","author":"Doumith","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/AAC.02835-15","article-title":"Association of novel nonsynonymous single nucleotide polymorphisms in ampD with cephalosporin resistance and phylogenetic variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae isolates that are highly resistant to carbapenems","volume":"60","author":"Babouee Flury","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/155.4.775","article-title":"\u03b2-Lactamase lability and inducer power of newer \u03b2-lactam antibiotics in relation to their activity against \u03b2-lactamase-inducibility mutants of Pseudomonas aeruginosa","volume":"155","author":"Livermore","year":"1987","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.idc.2016.02.007","article-title":"New \u03b2-lactamase inhibitors in the clinic","volume":"30","author":"Papp-Wallace","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B15","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/jac\/dkq248","article-title":"Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus \u03b2-lactamase-producing Enterobacteriaceae","volume":"65","author":"Livermore","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B16","author":"Farrell"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/AAC.00693-09","article-title":"Inhibitor resistance in the KPC-2 \u03b2-lactamase, a preeminent property of this class A \u03b2-lactamase","volume":"54","author":"Papp-Wallace","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/00222615-17-3-283","article-title":"Mechanisms of \u03b2-lactam resistance in British isolates of Pseudomonas aeruginosa","volume":"17","author":"Williams","year":"1984","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1099\/00222615-43-4-300","article-title":"Mechanisms of resistance to \u03b2-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993","volume":"43","author":"Chen","year":"1995","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0369-8114(01)00213-9","article-title":"Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of \u03b2-lactam resistance mechanisms: the GERPB 1999 study","volume":"49","author":"Cavallo","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/42.6.697","article-title":"Mechanisms of \u03b2-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey","volume":"42","author":"Bonfiglio","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/AAC.01645-10","article-title":"Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study","volume":"55","author":"Cabot","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1179\/1120009X12Z.00000000015","article-title":"Extended-spectrum and metallo-\u03b2-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia","volume":"24","author":"Al-Agamy","year":"2012","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1179\/joc.2007.19.2.140","article-title":"Widespread detection of VEB-1-type extended-spectrum \u03b2-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria","volume":"19","author":"Strateva","year":"2007","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(13)70168-3","article-title":"Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study","volume":"13","author":"Edelstein","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B26","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.02462-13","article-title":"Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC","volume":"58","author":"Cabot","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/28.6.837","article-title":"Effect of media composition on the susceptibility of Xanthomonas maltophilia to \u03b2-lactam antibiotics","volume":"28","author":"Bonfiglio","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/AAC.43.2.213","article-title":"Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis","volume":"43","author":"Bonacorsi","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B30","first-page":"1262","article-title":"Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane\/tazobactam","volume":"72","author":"Sousa-Dominguez","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02136-16","article-title":"Salvage therapy with ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections","volume":"61","author":"Cast\u00f3n","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s15010-016-0944-5","article-title":"Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane\/tazobactam","volume":"45","author":"Hern\u00e1ndez-Tejedor","year":"2017","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B33","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1002\/phar.1825","article-title":"Successful use of ceftolozane-tazobactam to treat a pulmonary exacerbation of cystic fibrosis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"36","author":"Vickery","year":"2016","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/civ411","article-title":"Ceftolozane\/tazobactam therapy of respiratory infections due to multidrug-resistant Pseudomonas aeruginosa","volume":"61","author":"Gelfand","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122641_dkx136-B35","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1128\/AAC.00825-15","article-title":"Mutations in \u03b2-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins","volume":"59","author":"Berrazeg","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/8\/2278\/24332344\/dkx136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:27:26Z","timestamp":1569043646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/8\/2278\/3829304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,16]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx136","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,5,16]]}}}